>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: DSCO -29%, MCP -21.6%, BOOM -12%, CALL-10.6%, PLUG -9.8%, XONE -7.6%, NOAH -6.8%, STEM -6.5%, WYY -4.8%, BDSI -4.1%, RTK -4%,EGY -3.8%, RFIL -3.8%, VEC -2.8%, ORAN -2.7% (guidance at analyst meetings), OMER -1.6%, IOC-1.4%, RSPP -1.3%, ZBRA -1.1%, AIQ -1%, ANW -0.7%, ARCO -0.5%

Select financial EU names showing weakness: ARMH -1.9%, BCS -1.6%, SHPG -1.6%, AEG-1.1%, RCL -1%, VOD -0.9%, NOK -0.8%, CCL -0.8%

Other news: CRZO -4.6% (prices 4,500,000 shares of its common stock at $45.50 per share), JKS-3.5% (announces Information from fire accident at one of its raw material processing workshops),JMBA -3.3% (filed to delay Form 10-K), HIMX -3.3% (cont weakness), MYE -2.5% (filed to delay Form 10-K; co has recently uncovered what appear to be errors in the accounting for inventory and possibly fraudulent activities at its Brazilian operations), QGEN -2.3% (confirms new partnership with Tokai Pharmaceuticals (TKAI) to combine new circulating tumor cells technology with a molecular assay),RTRX -2.2% (co offering to sell 5.1 mln shares of its common stock in an underwritten public offering),FCAU -2% (reports February automobiles sales in Europe), KCAP -1.9% (filed to delay Form 10-K), WD-1.7% (announced the commencement of a public secondary offering of 8,246,534 shares of common stock held by funds managed by affiliates of Fortress Investment Group LLC (FIG); In addition, co will repurchase from the Underwriter 3 mln of those shares), MBLY -0.8% (upsizes and prices 17,127,000 ordinary shares by selling shareholders at $41.75 per share)

Analyst comments: WTW -9.2% (downgraded to Underperform from Neutral at Credit Suisse; tgt lowered to $5 from $14), WLL -3.2% (downgraded to Neutral from Positive at Susquehanna), LNKD -2% (initiated with a Sell at Brean Capital), BLT -1.7% (downgraded to Sector Weight at Keybanc Capital Mkts), SIRO -1.4% (downgraded to Market Perform from Outperform at William Blair), ICPT -0.8% (initiated with a Hold at MLV & Co), GM -0.8% (resumed with a Underweight at Morgan Stanley)